[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gene Biotherapeutics Inc (CRXM) - Strategic SWOT Analysis Review

May 2020 | 25 pages | ID: G7C459FEE377EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Gene Biotherapeutics Inc (CRXM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Gene Biotherapeutics Inc (Gene Biotherapeutics), formerly Taxus Cardium Pharmaceuticals Group Inc, is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue engineering based on its core gene therapy. Its product portfolio includes Generx used for the treatment of cardiac microvascular insufficiency. The company also holds non-core interests in the Cell-nique d/b/a Healthy Brands Collective and LifeAgain Insurance Solutions, Inc. It markets its products through third party commercialization partners. Gene Biotherapeutics is headquartered in San Diego, California, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Gene Biotherapeutics Inc - Key Facts
Gene Biotherapeutics Inc - Key Employees
Gene Biotherapeutics Inc - Key Employee Biographies
Gene Biotherapeutics Inc - Major Products and Services
Gene Biotherapeutics Inc - History
Gene Biotherapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Gene Biotherapeutics Inc - Business Description
Gene Biotherapeutics Inc - Corporate Strategy
Gene Biotherapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Gene Biotherapeutics Inc - Strengths
Gene Biotherapeutics Inc - Weaknesses
Gene Biotherapeutics Inc - Opportunities
Gene Biotherapeutics Inc - Threats
Gene Biotherapeutics Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Gene Biotherapeutics Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Gene Biotherapeutics Inc, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Gene Biotherapeutics Inc, Key Facts
Gene Biotherapeutics Inc, Key Employees
Gene Biotherapeutics Inc, Key Employee Biographies
Gene Biotherapeutics Inc, Major Products and Services
Gene Biotherapeutics Inc, History
Gene Biotherapeutics Inc, Subsidiaries
Gene Biotherapeutics Inc, Key Competitors
Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Gene Biotherapeutics Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Gene Biotherapeutics Inc, Recent Deals Summary

LIST OF FIGURES

Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Gene Biotherapeutics Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Organogenesis Inc
MiMedx Group Inc
Juventas Therapeutics Inc
Collagen Solutions Plc
CardioVascular BioTherapeutics Inc
3-D Matrix Inc


More Publications